SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-027743
Filing Date
2023-06-13
Accepted
2023-06-13 16:55:13
Documents
12
Period of Report
2023-06-12
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K bolt-20230612.htm   iXBRL 8-K 80653
  Complete submission text file 0000950170-23-027743.txt   202189

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bolt-20230612_lab.xml EX-101.LAB 14018
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bolt-20230612_pre.xml EX-101.PRE 10277
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bolt-20230612.xsd EX-101.SCH 2454
6 EXTRACTED XBRL INSTANCE DOCUMENT bolt-20230612_htm.xml XML 4940
Mailing Address 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-665-9295
Bolt Biotherapeutics, Inc. (Filer) CIK: 0001641281 (see all company filings)

IRS No.: 472804636 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39988 | Film No.: 231011961
SIC: 2834 Pharmaceutical Preparations